Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by elgin1on Jan 16, 2018 9:53pm

117 Views

Post# 27373551

JDCA

JCDA is a repectable organization looking for the cure of diabetes. Basically in the report they are saying that Sernova technology is promising. Pointing out that Viacyte device fibrosis. Also sates that Sva will do further trials without immunosupression which is basically a cure for diabtetes.
Sva current trial uses immunosuppresion so it can gage the optimal dosing for cells to get maximum efficacy. Viacyte publicity stunt in the papers reeks of desperation. They even have a picture of the device that looks like a condom.

Bullboard Posts

Critical materials crisis: Diversifying away from China’s monopoly